This statistic shows the top therapy areas in the "pharmerging" markets as projected for 2018, by spending in billion US dollars. By 2018, expenditure on oncology in these markets is projected to reach between 12 and 14 billion U.S. dollars.
Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)*
Characteristic
Minimum estimate
Maximum estimate
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
* Forecast.
Spending in US$ with variable exchange rates. Growth in US$ with constant exchange rates. Specialty therapies are defined by IMS as products that are
often injectable, high-cost, biologic or requiring cold-chain distribution. They are mostly used by specialists, and include treatment for cancer and other
serious conditions, and often involve complex patient follow-up and monitoring. Therapy forecasts from IMS Health Therapy Prognosis Global October
2014 adapted by IMS Health Institute for Healthcare Informatics to represent global sales and to include additional therapy classes. Abbreviations: ADHD:
Attention-Deficit Hyperactivity Disorder; CNS: Central Nervous System; HIV: Human Immunodeficiency Virus.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IMS Health (Institute for Healthcare Informatics). (November 24, 2014). Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)* [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/281960/top-therapy-classes-in-pharmerging-markets-by-spending/
IMS Health (Institute for Healthcare Informatics). "Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)*." Chart. November 24, 2014. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/281960/top-therapy-classes-in-pharmerging-markets-by-spending/
IMS Health (Institute for Healthcare Informatics). (2014). Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/281960/top-therapy-classes-in-pharmerging-markets-by-spending/
IMS Health (Institute for Healthcare Informatics). "Top Therapy Areas in Pharmerging Markets in 2018, by Spending (in Billion U.S. Dollars)*." Statista, Statista Inc., 24 Nov 2014, https://www.statista.com/statistics/281960/top-therapy-classes-in-pharmerging-markets-by-spending/
IMS Health (Institute for Healthcare Informatics), Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/281960/top-therapy-classes-in-pharmerging-markets-by-spending/ (last visited July 22, 2024)
Top therapy areas in pharmerging markets in 2018, by spending (in billion U.S. dollars)* [Graph], IMS Health (Institute for Healthcare Informatics), November 24, 2014. [Online]. Available: https://www.statista.com/statistics/281960/top-therapy-classes-in-pharmerging-markets-by-spending/
